Nexpowder
Device Therapeutic Endoscopy
PDI 08800038405189
General payments
$47,873
Research payments
$532,211
Through program year 2025, $47,873 in general payments and $532,211 in research payments were reported against Nexpowder (Therapeutic Endoscopy).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
6 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $15,787 | 212 |
| 2025 | Research | $245,869 | 26 |
| 2024 | General | $17,207 | 303 |
| 2024 | Research | $272,317 | 25 |
| 2023 | General | $14,879 | 144 |
| 2023 | Research | $14,025 | 1 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 18 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 27 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
659 general · 52 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.